A Case of Acromegaly With Progressed Diabetic Retinopathy and Sarcopenia Diagnosed Following the Onset of Severe Hypoglycemia
- PMID: 38765413
- PMCID: PMC11100447
- DOI: 10.7759/cureus.58461
A Case of Acromegaly With Progressed Diabetic Retinopathy and Sarcopenia Diagnosed Following the Onset of Severe Hypoglycemia
Abstract
Acromegaly is a rare disorder characterized by excessive production of growth hormone (GH) from a pituitary tumor, typically leading to elevated glucose levels due to increased insulin resistance; hypoglycemia is rare. However, the long-term effect of excess GH on the peripheral organs is still unclear. Here we present a 69-year-old man evaluated for the cause of a hypoglycemic episode. He was underweight (body mass index: 17.3 kg/m2) with sarcopenia, which potentially contributed to his hypoglycemia. Notably, he exhibited progressed proliferative diabetic retinopathy compared to other microvascular complications, leading to further endocrinological investigation. As a result, he was diagnosed with acromegaly showing elevated GH and insulin-like growth factor-1 (IGF-1) with a pituitary tumor. Opting against transsphenoidal surgery (TSS), the patient was treated with a somatostatin analog (SSA), achieving normalized IGF-1 levels with a monthly 120 mg lanreotide injection. In this case, acromegaly could lead to sarcopenia from GH-derived gluconeogenesis in the peripheral organs such as the reduction of muscle leading to reduced glucose reserves. Acromegaly in the elderly may present atypicality. Clinicians should be vigilant for unique manifestations such as advanced diabetic retinopathy, even in elderly patients with hypoglycemia.
Keywords: acromegaly; diabetic retinopathy; hypoglycemia; insulin autoimmune disease; sarcopenia.
Copyright © 2024, Kubo et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures





Similar articles
-
Impact of tumor characteristics and pre- and postoperative hormone levels on hormonal remission following endoscopic transsphenoidal surgery in patients with acromegaly.Neurosurg Focus. 2020 Jun;48(6):E10. doi: 10.3171/2020.3.FOCUS2080. Neurosurg Focus. 2020. PMID: 32480366
-
A rare challenging case of co-existent craniopharyngioma, acromegaly and squamous cell lung cancer.Endocrinol Diabetes Metab Case Rep. 2018 Mar 28;2018:18-0018. doi: 10.1530/EDM-18-0018. eCollection 2018. Endocrinol Diabetes Metab Case Rep. 2018. PMID: 29623208 Free PMC article.
-
Body mass index and insulin-like growth factor 1 as risk factors for discordant growth hormone and insulin-like growth factor 1 levels following pituitary surgery in acromegaly.J Formos Med Assoc. 2018 Jan;117(1):34-41. doi: 10.1016/j.jfma.2017.02.014. Epub 2017 Mar 21. J Formos Med Assoc. 2018. PMID: 28341329
-
Medical treatment of acromegaly: comorbidities and their reversibility by somatostatin analogs.Neuroendocrinology. 2006;83(3-4):249-57. doi: 10.1159/000095535. Epub 2006 Oct 13. Neuroendocrinology. 2006. PMID: 17047390 Review.
-
How effective are current therapies for acromegaly?Growth Horm IGF Res. 2003 Aug;13 Suppl A:S144-51. doi: 10.1016/s1096-6374(03)00072-8. Growth Horm IGF Res. 2003. PMID: 12914744 Review.
References
-
- A consensus on the diagnosis and treatment of acromegaly comorbidities: an update. Giustina A, Barkan A, Beckers A, et al. J Clin Endocrinol Metab. 2020;105:0–46. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous